The American Journal of Medicine
Volume 113, Issue 7 , Pages 596-602, November 2002

Transient proarrhythmic state following atrioventricular junction radiofrequency ablation: pathophysiologic mechanisms and recommendations for management

  • Karolina Nowinski, MD, PhD

      Affiliations

    • Department of Cardiology, Karolinska Institutet at Karolinska Hospital, Stockholm, Sweden
  • ,
  • Fredrik Gadler, MD, PhD

      Affiliations

    • Department of Cardiology, Karolinska Institutet at Karolinska Hospital, Stockholm, Sweden
  • ,
  • Mats Jensen-Urstad, MD, PhD

      Affiliations

    • Department of Cardiology, Karolinska Institutet at Karolinska Hospital, Stockholm, Sweden
  • ,
  • Lennart Bergfeldt, MD, PhD

      Affiliations

    • Department of Cardiology, Karolinska Institutet at Karolinska Hospital, Stockholm, Sweden
    • Corresponding Author InformationRequests for reprints should be addressed to Lennart Bergfeldt, MD, PhD, Electrophysiology and Arrhythmia Service, Department of Cardiology, Thoracic Clinics, Karolinska Hospital, S-171 76 Stockholm, Sweden

Received 26 September 2001; received in revised form 30 May 2002; accepted 25 June 2002.

Abstract 

The induction of complete heart block by radiofrequency ablation of the atrioventricular junction combined with pacemaker implantation has become an established therapy for rate control in patients with atrial fibrillation who are unresponsive to drugs. Reports of ventricular arrhythmias and sudden death after ablation have, however, raised concerns about safety. Ventricular arrhythmias are usually polymorphic and related to a phase of electrical instability due to an initial prolongation and then slow adaptation of repolarization caused by the change in heart rate and activation sequence. Structural heart disease, and other factors that predispose for the acquired long QT syndrome, seem to add to the risk. Ventricular activation and repolarization stabilize during the first week after the procedure. Routine pacing at 80 beats per minute during this phase is recommended, as well as in hospital monitoring for at least 48 hours. Patients with high-risk features for arrhythmias, such as congestive heart failure or impaired left ventricular function, may require pacing at higher rates. Adjustment of the pacing rate—although rarely below 70 beats per minute—is usually undertaken after a week in most patients, preferably after an electrocardiographic evaluation for repolarization abnormalities at the lower rate.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by grants from Karolinska Institutet, and the Swedish Heart-Lung Foundation for which Dr. Bergfeldt is a clinical investigator.

PII: S0002-9343(02)01274-3

The American Journal of Medicine
Volume 113, Issue 7 , Pages 596-602, November 2002